Leukocytosis and hypoalbuminemia in mixed bipolar states: Evidence for immune activation

Acta Psychiatrica Scandinavica

Volumn 105, Issue 1, 2002, Pages 60-64

  Cassidy, Frederick ^a,b   Wilson, William H ^a   Carroll, Bernard J ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Acute phase reactant; Albumin; Immune response; Leukocyte; Mania; Mixed states; Sex

Indexed keywords

ALBUMIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; DEPRESSION; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; HYPOALBUMINEMIA; IMMUNE RESPONSE; IMMUNOPATHOLOGY; LEUKOCYTOSIS; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MANIA; MANIC DEPRESSIVE PSYCHOSIS; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL;

ALBUMINS; BIPOLAR DISORDER; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LEUKOCYTES; MALE; PSYCHIATRIC STATUS RATING SCALES;

EID: 0036174320     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0447.2002.0_435.x     Document Type: Article

References (52)

1. Evidence for an immune response in major depression: A review and hypothesis
2. Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression
3. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression
4. Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine
5. Indicators of immune activation in major depression
6. Lymphocyte mitogenesis, immunoglobulin and complement levels in depressed patients and normal controls
7. Major depressive disorder, alcoholism, and reduced natural killer cell cytotoxicity
8. Leukocytosis, monocytosis and neutrophilia: Hallmarks of severe depression
9. Disturbances in acute phase plasma proteins during melancholia: Additional evidence for the presence of an inflammatory process during that illness
10. A review of the acute phase response in major depression
11. Interleukin-2 and interleukin-6 in schizophrenia and mania: Effects of neuroleptic and mood stabilizers
12. Acute phase proteins in schizophrenia, mania and major depression: Modulation by psychotropic drugs
13. Signs and symptoms of mania in pure and mixed episodes
14. Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania
15. A factor analysis of the signs and symptoms of mania
16. A specific laboratory test for the diagnosis of melancholia: Standardization, validation and clinical utility
17. Abnormal cortisol suppression in bipolar patients with simultaneous manic and depressive symptoms
18. The dexamethasone suppression test in mixed bipolar disorder
19. Hypothalamic-pituitary-adrenocortical function in mixed and pure mania
20. Plasma dexamethasone concentration and cortisol response during manic episodes
21. Albumin decrement in depression and cholesterol decrement in mania
22. The clinical laboratory and electroencephalographic effects of lithium
23. Leukocytosis during lithium carbonate treatment
24. Lithium and leukocytosis
25. Leukocytosis during lithium treatment
26. Hematological effects of carbamazepine in patients with affective illness
27. Clinical and metabolic study of 11-dehydroxy-17-hydroxy-corticosterone acetate (Kendall Compound E) in hypertension, Addison's disease and diabetes mellitus
28. Blood levels of 17-hydroxycorticosteroids following the administration of adrenal steroids and their relation to levels of circulating leukocytes
29. Changes in white blood cell counts after administration of cortisone acetate to healthy ambulatory individuals
30. Comparison of agents producing a neutrophilic leukocytosis in man
31. The diurnal variation of blood leucocytes in normal and adrenalectomized mice
32. Sources of physiological variation in differential leukocyte counting
33. Rythmes circadiens et circannuels des leucocytes, proteines totales, immunoglobulines A, G, et M
34. Causes of hypoalbuminemia
35. Plasma proteins in normal individuals
36. The normal ranges, with statistical analysis for seventeen blood constituents
37. Estimation of normal ranges from a controlled sample survey. I. Sex- and age-related influence on the SMA 12/60 screening group of tests
38. Diagnostic depressive symptoms of the mixed bipolar episode
39. Review article: Interleukin-6 and the acute phase response
40. IL-6 modulates the synthesis of a specific set of acute phase plasma proteins in vivo
41. Interleukins-1 and -6 stimulate the release of corticotropin-releasing hormone hormone 41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway
42. Interleukin-6 stimulates the secretion of adrenocorticotropic hormone in conscious freely-moving rats
43. Corticotropin-releasing activity of monokines
44. Effects of recombinant human interleukin-1 alpha, -1 beta, 2 and 6 on ACTH synthesis and release in the mouse pituitary tumor cell line AtT-20
45. Prostaglandin-dependent in vitro stimulation of adrenocortical steroidogenesis by interleukins
46. Evaluation of marrow granulocytic reserves in normal and disease states
47. Leukokinetic studies. XIII. A nonsteady-state kinetic evaluation of the mechanism of cortisone-induced granulocytosis
48. Leukokinetic studies IV. The total blood circulating and marginal granulocyte pools and the granulocyte turnover rate in normal subjects
49. Alternate-day prednisone leukocyte kinetics and susceptibility to infections
50. Epidemiology of affective disorders
51. The clinical epidemiology of pure and mixed manic episodes